Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clinics ; 64(2): 143-148, 2009. ilus, tab
Artigo em Inglês | LILACS | ID: lil-505376

RESUMO

BACKGROUND: Adhesion formation after peritoneal surgery is a major cause of postoperative bowel obstruction, infertility, and chronic pelvic pain. In this study, we compared the possible individual effects of phosphatidylcholine (PC), Seprafilm® II, and tissue plasminogen activator (t-PA) and the combined effects of phosphatidylcholine and t-PA on postoperative adhesion formation in a rat surgical model. MATERIALS AND METHODS: A total of 50 Wistar male rats underwent median laparotomy and standardized abrasion of the visceral and parietal peritoneum. phosphatidylcholine, Seprafilm II, and t-PA alone and phosphatidylcholine and t-PA in combination were applied intraperitoneally at the end of the surgical procedure. Seven days after surgery, a relaparotomy was performed for adhesion grading and histopathological examination. RESULTS: A comparison of adhesion stages demonstrated a significant difference between the control group and the study groups (p<0.001). The adhesion grade of the combined treatment group was statistically different from that of the other groups (p<0.05). In the t-PA group and the combined group, six and two rats, respectively, developed hematomas locally on the cecum. CONCLUSIONS: PC, t-PA, and Seprafilm II used individually reduced the adhesion grade. The t-PA and phosphatidylcholine combination was most effective in reducing adhesion formation. On the other hand, usage of t-PA alone or in combination may increase risk of bleeding. More detailed studies are needed, and future studies on the efficacy of a material for decreasing adhesion formation should include a comparison of several control materials in the same model.


Assuntos
Animais , Masculino , Ratos , Fibrinolíticos/uso terapêutico , Ácido Hialurônico/uso terapêutico , Doenças Peritoneais/tratamento farmacológico , Fosfatidilcolinas/uso terapêutico , Complicações Pós-Operatórias/tratamento farmacológico , Ativador de Plasminogênio Tecidual/uso terapêutico , Modelos Animais de Doenças , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Doenças Peritoneais/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle , Ratos Wistar , Aderências Teciduais/tratamento farmacológico , Aderências Teciduais/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA